Pulmonx Corporation (LUNG)

Theseus Pharmaceuticals Revenue

Pulmonx had revenue of $23.86M in the quarter ending June 30, 2025, with 14.80% growth. This brings the company's revenue in the last twelve months to $90.55M, up 18.24% year-over-year. In the year 2024, Pulmonx had annual revenue of $83.79M with 22.01% growth.

• Revenue (ttm): $90.55M
• Revenue Growth: +18.24%
• P/S Ratio: 0.71
• Revenue / Employee: $311,165
• Employees: 291
• Market Cap: 64.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	83.79M	15.11M	22.01%
Dec 31, 2023	68.68M	15.01M	27.98%
Dec 31, 2022	53.66M	5.25M	10.84%
Dec 31, 2021	48.42M	15.68M	47.91%
Dec 31, 2020	32.73M	138.00K	0.42%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.